Literature DB >> 16105658

Vascular endothelial growth factor receptors in osteoclast differentiation and function.

S E Aldridge1, T W J Lennard, J R Williams, M A Birch.   

Abstract

Osteoclasts are derived from haematopoietic stem cell precursors of the monocyte/macrophage cell lineage, through interaction with factors that are believed to include M-CSF and RANKL. VEGF is a proangiogenic cytokine that has been shown to promote osteoclast differentiation and survival. In this study, we assessed the role of VEGF and its receptors in osteoclastogenesis, in vitro, by culturing osteoclast precursors in the presence of VEGF, VEGF receptor-specific ligands, and blocking antibodies to VEGF receptors. Activation of VEGFR1 in the presence of RANKL induces osteoclast differentiation. Stimulating the receptors individually induced increased resorption by osteoclasts compared to controls but not to the level observed when stimulating both receptors simultaneously. We have shown that VEGF induces osteoclast differentiation through its action on VEGFR1. The way in which VEGF mediates its effect on mature osteoclast activity, however, may be through its interaction with both receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105658     DOI: 10.1016/j.bbrc.2005.07.145

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications.

Authors:  Antonio Garcia-Gomez; Enrique M Ocio; Atanasio Pandiella; Jesús F San Miguel; Mercedes Garayoa
Journal:  Invest New Drugs       Date:  2012-07-07       Impact factor: 3.850

Review 2.  The roles of vascular endothelial growth factor in bone repair and regeneration.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Bone       Date:  2016-06-25       Impact factor: 4.398

Review 3.  Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Authors:  John L Hamilton; Masashi Nagao; Brett R Levine; Di Chen; Bjorn R Olsen; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2016-04-08       Impact factor: 6.741

4.  Electrical stimulation enhances tissue reorganization during orthodontic tooth movement in rats.

Authors:  Gisele Sampaio Spadari; Ewerton Zaniboni; Silvia Amelia Scudeler Vedovello; Mauro Pedrine Santamaria; Maria Esméria Corezola do Amaral; Gláucia Maria Tech Dos Santos; Marcelo Augusto Marretto Esquisatto; Fernanda Aparecida Sampaio Mendonca; Milton Santamaria
Journal:  Clin Oral Investig       Date:  2016-02-26       Impact factor: 3.573

5.  Bevacizumab-related osteonecrosis of the mandible is a self-limiting disease process.

Authors:  Giordana Bettini; Stella Blandamura; Giorgia Saia; Alberto Bedogni
Journal:  BMJ Case Rep       Date:  2012-10-22

6.  Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones.

Authors:  Christa Maes; Steven Goossens; Sonia Bartunkova; Benjamin Drogat; Lieve Coenegrachts; Ingrid Stockmans; Karen Moermans; Omar Nyabi; Katharina Haigh; Michael Naessens; Lieven Haenebalcke; Jan P Tuckermann; Marc Tjwa; Peter Carmeliet; Vice Mandic; Jean-Pierre David; Axel Behrens; Andras Nagy; Geert Carmeliet; Jody J Haigh
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

7.  Two cases of breast carcinoma with osteoclastic giant cells: are the osteoclastic giant cells pro-tumoural differentiation of macrophages?

Authors:  Yukiko Shishido-Hara; Atsushi Kurata; Masachika Fujiwara; Hiroki Itoh; Shigeru Imoto; Hiroshi Kamma
Journal:  Diagn Pathol       Date:  2010-08-23       Impact factor: 2.644

8.  Spontaneous In Vivo Chondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling.

Authors:  Anna Marsano; Carolina M Medeiros da Cunha; Shahram Ghanaati; Sinan Gueven; Matteo Centola; Roman Tsaryk; Mike Barbeck; Chiara Stuedle; Andrea Barbero; Uta Helmrich; Stefan Schaeren; James C Kirkpatrick; Andrea Banfi; Ivan Martin
Journal:  Stem Cells Transl Med       Date:  2016-07-26       Impact factor: 6.940

9.  Anti-VEGFR therapy is one of the healing inhibitors of antiresorptive-related osteonecrosis of the jaw.

Authors:  Chihiro Kanno; Tetsuharu Kaneko; Manabu Endo; Takehiro Kitabatake; Tomoko Sakuma; Yoshiaki Kanaya; Yuki Watanabe; Hiroshi Hasegawa
Journal:  J Bone Miner Metab       Date:  2020-11-16       Impact factor: 2.626

10.  Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.